,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['paradigm', 'congrat', 'db04']
practice changing is often thrown around nonchalantly. not here. #db04 is #paradigmshifting congrats to investigators and my friend #asco22 
Chief MedOnc @SylvesterCancer. Helping improve Cancer Control in LMICs. Editor-in-Chief @JCOGO_ASCO, Board Member @UICC - co-chair #ATOMcoalition